Atb Cap Markets Reduces Earnings Estimates for TerrAscend

TerrAscend Corp. (OTCMKTS:TSNDF) – Analysts at Atb Cap Markets dropped their FY2024 earnings per share (EPS) estimates for shares of TerrAscend in a research note issued to investors on Wednesday, November 6th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of ($0.20) for the year, down from their previous forecast of ($0.14). The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share. Atb Cap Markets also issued estimates for TerrAscend’s Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.09) EPS.

TerrAscend (OTCMKTS:TSNDF) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. The business had revenue of $77.52 million for the quarter, compared to the consensus estimate of $80.70 million.

Separately, Ventum Cap Mkts raised TerrAscend to a “strong-buy” rating in a report on Friday, August 9th.

TerrAscend Stock Up 1.4 %

Shares of OTCMKTS:TSNDF opened at $0.92 on Monday. The business has a fifty day moving average of $1.17 and a 200-day moving average of $1.36. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35. TerrAscend has a twelve month low of $0.74 and a twelve month high of $2.45.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.